Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Clémentine Carlet"'
Autor:
Clémentine Carlet, Damien Bichard, Marie Aleth Richard, Emmanuel Mahé, Clémence Saillard, Emilie Brenaut, Alain Dupuy, Laurent Misery, Axel Villani, Denis Jullien, Eve Puzenat, Charlée Nardin, François Aubin, Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie
Publikováno v:
Dermatology Research and Practice, Vol 2020 (2020)
Background. Although infliximab (IFX) has been available since 2005, there are very little data on the long-term drug survival of infliximab in real-life. Objective. Our aim was to identify and describe psoriasis patients treated with IFX for longer
Externí odkaz:
https://doaj.org/article/da98430076a145c78b588a749047f6bd
Autor:
Julie De Quatrebarbes, S. Dalac-Rat, Henri Montaudié, Clara Allayous, Olivier Dereure, Brigitte Dréno, Caroline Dutriaux, Myrtille Le-Bouar, Julie Charles, Céleste Lebbé, Florence Granel-Brocard, Charlée Nardin, Stéphane Dalle, Wendy Lefevre, Marie-Thérèse Leccia, Florence Brunet-Possenti, Laurent Mortier, Delphine Legoupil, Clémentine Carlet
Publikováno v:
Journal of the American Academy of Dermatology. 86:345-352
Late-onset adverse events (AEs) of anti-programmed cell death 1 (anti-PD1) antibodies have not been systematically described.The purpose was to evaluate late-onset AEs in melanoma patients treated with anti-PD1 administered for at least 2 years in a
Autor:
Eve Puzenat, Irène Gallais-Serezal, Flora Dresco, Romain Charollais, Laure Frechet, Clémentine Carlet, Charlée Nardin, François Aubin
Publikováno v:
European journal of dermatology : EJD. 31(1)
Background Dissecting cellulitis of the scalp (DCS), also known as Hoffmann disease or perifolliculitis capitis abscedens et suffodiens, is a rare disease characterized by chronic inflammation of the scalp. Treatment is difficult and often disappoint
Autor:
Clémentine Carlet, Marie Blanche Valnet-Rabier, Julie Castagna, Charlée Nardin, Kevin Bouiller, Flora Dresco, Virginie Nerich, François Aubin, Eve Puzenat, Samuel Limat, Adrien Mareschal, Anne Jeand'heur
Publikováno v:
Journal of The American Academy of Dermatology
Journal of The American Academy of Dermatology, Elsevier, 2020, 82 (3), pp.770-772. ⟨10.1016/j.jaad.2019.11.017⟩
Journal of The American Academy of Dermatology, Elsevier, 2020, 82 (3), pp.770-772. ⟨10.1016/j.jaad.2019.11.017⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d054e20ec5d489e7775983a14ec4ae33
https://hal.archives-ouvertes.fr/hal-02559044
https://hal.archives-ouvertes.fr/hal-02559044
Autor:
Brice Châtelain, E. Euvrard, Marie-Christine Thiebaut-Drobacheff, Maxime Delarue, Clémentine Carlet, Aurélien Louvrier
Publikováno v:
Journal of Oral Medicine and Oral Surgery, Vol 26, Iss 3, p 26 (2020)
Mycoplasma pneumoniae induced rash and mucositis (MIRM) is a distinct entity of erythema multiforma spectrum. Observation: we report a case of a 19-year-old man hospitalised for multiple mucosal eruptions and hyperthermia for three days, in context o
Autor:
Florence Brunet-Possenti, Clara Allayous, M.-T. Leccia, S. Dalle, Florence Granel-Brocard, Wendy Lefevre, Clémentine Carlet, C. Lebbé, Julie Charles, M. Le Bouar, L. Mortier, Sophie Dalac-Rat, J. De Quatrebarbes, C. Dutriaux, Olivier Dereure, D. Legoupil, H. Montaudié, Charlée Nardin, B. Dréno
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 147:A81-A82
Introduction Les anti-PD1 sont associes a la survenue d’effets indesirables (EI) specifiques, en partie medies par l’immunite. Les patients atteints de melanomes avances inclus dans des essais cliniques ont ete traites par anti-PD1 pour une duree
Publikováno v:
Contact Dermatitis. 81:215-216